About this trial
The goal of this clinical trial is to evaluate whether the integration of in-person skills practice (ISP) with an adaptive e-learning platform can improve refresher learning progress (RLP) among healthcare providers in pediatric care settings in Tanzania.
The main questions it aims to answer are:
Can healthcare providers who participate in ISP sessions facilitated by clinical champions achieve greater improvements in refresher learning progress (RLP)? Will providers in the intervention group demonstrate improved metacognition and practical skill performance compared to those in the control group? Researchers will compare healthcare providers using the ISP digital platform (Rhapsode Capable™) to providers using paper-based ISP to see if the digital platform results in significantly higher RLP and fewer skill-based errors.
Participants will:
Complete adaptive e-learning modules focused on pediatric care topics (e.g., newborn resuscitation, severe malnutrition).
Participate in ISP sessions where clinical champions provide feedback and assess performance.
Eligibility criteria
Qualifiers
Healthcare providers actively involved in pediatric care at one of the selected healthcare centers.
Completion of core Pediatric Acute Care Education (PACE) adaptive learning modules prior to study participation.
Willingness to participate in In-Person Skills Practice (ISP) sessions.
Ability to engage with either the Rhapsode Capable™ platform (intervention group) or paper-based ISP methods (control group).
Disqualifiers
Healthcare providers not involved in pediatric or newborn clinical care at the time of recruitment.
Providers unable or unwilling to attend ISP sessions facilitated by clinical champions.
Individuals with no prior engagement in the PACE program.
Providers with significant technological barriers that prevent the use of the Rhapsode Capable™ platform (for the intervention group only).
Trial design
Treatments tested in this trial
- Rhapsode Capable™ Platform (Intervention Group)
- Paper-based ISP (Control Group)
Treatment groups
Sponsors and collaborators
Stanford University
Lead sponsor
Catholic University of Health and Allied Sciences
Collaborator
London School of Hygiene and Tropical Medicine
Collaborator
National Institutes of Health (NIH)
Collaborator